Tetrahedral framework nucleic acids as an advanced drug delivery system for oligonucleotide drugs

Yuhao Liu,Zhiqiang Liu,Weitong Cui,Yanjing Li,Xin Qin,Mei Zhang,Yunfeng Lin

DOI: https://doi.org/10.1063/5.0025211

IF: 6.6351

2020-10-01

APL Materials

Abstract:Nucleic acid therapy has played a promising role in the treatment of many diseases, such as cancer, infections, immune diseases, and neurodegenerative diseases. However, its application is still limited mainly because of poor cell-entry performance and low resistance to <i>in vivo</i> degradation. Tetrahedral framework nucleic acids (tFNAs) have shown potential in delivering low-molecular-weight drugs owing to their stability, biocompatibility, cell-entry performance, and flexible drug-loading ability. In particular, tFNAs can successfully deliver oligonucleotide drugs with improved effects and co-deliver oligonucleotide drugs with other drugs for synergistic effects. In this review, the recent progress on tFNA-based delivery of oligonucleotide drugs is outlined by single delivery systems—through sequence extension and complementation, and co-delivery systems—through multiple sequence extension, drug–DNA interactions, and specific binding. Furthermore, the current limitations and future developments of tFNA-based delivery of oligonucleotide drugs are discussed.

materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology